Jack Anders - 24 Jun 2026 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 Jun 2026, 16:10:03 UTC
Prior SEC filing
18 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jack Anders

Key filing fact

Jack Anders filed Form 4 for Revolution Medicines, Inc. (RVMD) on 26 Jun 2026.

Key facts

  • This page summarizes Jack Anders's Form 4 filing for Revolution Medicines, Inc. (RVMD).
  • 6 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 26 Jun 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 18 Jun 2026.
  • Current net transaction value: -$3,366,604.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001800668 Primary reporting owner

Anders Jack

Relationship
Chief Financial Officer
Address
C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY
Signature
/s/ Jack Anders
Signature date
26 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVMD transaction

Common Stock

Options Exercise

Transaction value
Shares
+20,000
Change %
+16%
Price
$18.56*
Shares after
143,269
Date
24 Jun 2026
Ownership
Direct
Footnotes
F1, F2
RVMD transaction

Common Stock

Sale

Transaction value
$761,922
Shares
-4,553
Change %
-3.2%
Price
$167.34
Shares after
138,716
Date
24 Jun 2026
Ownership
Direct
Footnotes
F1, F2, F3
RVMD transaction

Common Stock

Sale

Transaction value
$1,597,188
Shares
-9,496
Change %
-6.8%
Price
$168.20
Shares after
129,220
Date
24 Jun 2026
Ownership
Direct
Footnotes
F1, F2, F4
RVMD transaction

Common Stock

Sale

Transaction value
$956,398
Shares
-5,651
Change %
-4.4%
Price
$169.24
Shares after
123,569
Date
24 Jun 2026
Ownership
Direct
Footnotes
F1, F2, F5
RVMD transaction

Common Stock

Sale

Transaction value
$51,096
Shares
-300
Change %
-0.24%
Price
$170.32
Shares after
123,269
Date
24 Jun 2026
Ownership
Direct
Footnotes
F1, F2, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RVMD transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
+20,000
Change %
+3333%
Price
$0.000000*
Shares after
20,600
Date
24 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$18.56
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 24, 2026.

Footnote F2

Includes 51,388 restricted stock units.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $166.76 to $167.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F4

This transaction was executed in multiple trades at prices ranging from $167.77 to $168.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F5

This transaction was executed in multiple trades at prices ranging from $168.78 to $169.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F6

This transaction was executed in multiple trades at prices ranging from $169.81 to $170.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .